BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25794571)

  • 1. A patient-reported outcome measures-based composite index (RAPID3) for the assessment of disease activity in ankylosing spondylitis.
    Cinar M; Yilmaz S; Cinar FI; Koca SS; Erdem H; Pay S; Dinc A; Yazici Y; Simsek I
    Rheumatol Int; 2015 Sep; 35(9):1575-80. PubMed ID: 25794571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine Assessment of Patient Index Data (RAPID3) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Scores Yield Similar Information in 85 Korean Patients With Ankylosing Spondylitis Seen in Usual Clinical Care.
    Park SH; Choe JY; Kim SK; Lee H; Castrejón I; Pincus T
    J Clin Rheumatol; 2015 Sep; 21(6):300-4. PubMed ID: 26308349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine Assessment of Patient Index Data 3 score (RAPID3) correlates well with Bath Ankylosing Spondylitis Disease Activity index (BASDAI) in the assessment of disease activity and monitoring progression of axial spondyloarthritis.
    Danve A; Reddy A; Vakil-Gilani K; Garg N; Dinno A; Deodhar A
    Clin Rheumatol; 2015 Jan; 34(1):117-24. PubMed ID: 25421013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responsiveness of a simple RAPID-3-like index compared to disease-specific BASDAI and ASDAS indices in patients with axial spondyloarthritis.
    Castrejón I; Pincus T; Wendling D; Dougados M
    RMD Open; 2016; 2(2):e000235. PubMed ID: 27486525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construct Validity of the Routine Assessment of Patient Index Data 3 (RAPID3) in the Evaluation of Axial Spondyloarthritis.
    García-Valle A; Andrés-de Llano JM; Fariña-González AJ; González-Benítez RD; Queiro-Silva R
    J Rheumatol; 2022 Jan; 49(1):36-43. PubMed ID: 34266987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.
    Salaffi F; Ciapetti A; Carotti M; Gasparini S; Citera G; Gutierrez M
    Health Qual Life Outcomes; 2014 Aug; 12():129. PubMed ID: 25146299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance characteristics of the simplified version of ankylosing spondylitis disease activity score (SASDAS).
    Solmaz D; Yildirim T; Avci O; Tomas N; Akar S
    Clin Rheumatol; 2016 Jul; 35(7):1753-8. PubMed ID: 26670454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of the ASDAS index in comparison with BASDAI in patients with ankylosing spondylitis (Axis Study).
    Sellas I Fernandez A; Juanola Roura X; Alonso Ruiz A; Rosas J; Medina Luezas J; Collantes Estevez E; Abad Hernández MÁ; Carrasco Benitez V; Fisac C
    Rheumatol Int; 2017 Nov; 37(11):1817-1823. PubMed ID: 28918450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of ankylosing spondylitis disease activity score in evaluating disease activity of ankylosing spondylitis].
    DU XN; Li Y; Zhang SL; Zhu J; Huang F
    Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):206-9. PubMed ID: 22781894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
    Kilic E; Kilic G; Akgul O; Ozgocmen S
    Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simplified version of Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with ankylosing spondylitis.
    Sommerfleck FA; Schneeberger EE; Buschiazzo EE; Maldonado Cocco JA; Citera G
    Clin Rheumatol; 2012 Nov; 31(11):1599-603. PubMed ID: 22895877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Scoring of disease activity using BASDAI and ASDAS method in ankylosing spondylitis].
    Bobek D; Zagar I; Kovač-Durmiš K; Perić P; Ćurković B; Babić-Naglić Ð
    Reumatizam; 2012; 59(1):5-10. PubMed ID: 25486721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore.
    Kwan YH; Tan JJ; Phang JK; Fong W; Lim KK; Koh HL; Lui NL; Tan CS; Østbye T; Thumboo J; Leung YY
    Int J Rheum Dis; 2019 Dec; 22(12):2206-2212. PubMed ID: 31721427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease activity assessment in ankylosing spondylitis in a Chinese cohort: BASDAI or ASDAS?
    Au YL; Wong WS; Mok MY; Chung HY; Chan E; Lau CS
    Clin Rheumatol; 2014 Aug; 33(8):1127-34. PubMed ID: 24981160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study.
    Michielsens C; Bolhuis TE; van Gaalen FA; van den Hoogen F; Verhoef LM; den Broeder N; den Broeder AA
    Scand J Rheumatol; 2024 May; 53(3):180-187. PubMed ID: 37339375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASDAS high disease activity versus BASDAI elevation in patients with ankylosing spondylitis as selection criterion for anti-TNF therapy.
    Vastesaeger N; Cruyssen BV; Mulero J; Gratacós Masmitjá J; Zarco P; Almodovar R; Font P; Juanola X; Collantes-Estevez E;
    Reumatol Clin; 2014; 10(4):204-9. PubMed ID: 24598027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme.
    Fernández-Espartero C; de Miguel E; Loza E; Tomero E; Gobbo M; Descalzo MA; Collantes-Estévez E; Mulero J; Muñoz-Fernández S; Zarco P; Carmona L;
    Ann Rheum Dis; 2014 Jul; 73(7):1350-5. PubMed ID: 23709245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study.
    Nam B; Koo BS; Lee TH; Shin JH; Kim JJ; Lee S; Joo KB; Kim TH
    BMC Musculoskelet Disord; 2021 Feb; 22(1):140. PubMed ID: 33541326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis?
    Kilic G; Kilic E; Ozgocmen S
    Int J Rheum Dis; 2017 Sep; 20(9):1201-1211. PubMed ID: 27309497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of disease activity and functional status questionnaires in spondyloarthritis.
    Quinzanos I; Luong PT; Bobba S; Steuart Richards J; Majithia V; Davis LA; Caplan L
    Clin Exp Rheumatol; 2015; 33(2):146-52. PubMed ID: 25664820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.